DK140214C - - Google Patents

Info

Publication number
DK140214C
DK140214C DK301775A DK301775A DK140214C DK 140214 C DK140214 C DK 140214C DK 301775 A DK301775 A DK 301775A DK 301775 A DK301775 A DK 301775A DK 140214 C DK140214 C DK 140214C
Authority
DK
Denmark
Application number
DK301775A
Other languages
Danish (da)
Other versions
DK301775A (en:Method
DK140214B (da
Inventor
A Soeder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK301775A publication Critical patent/DK301775A/da
Priority to DK169377A priority Critical patent/DK142790B/da
Priority to DK169277A priority patent/DK169277A/da
Publication of DK140214B publication Critical patent/DK140214B/da
Application granted granted Critical
Publication of DK140214C publication Critical patent/DK140214C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK301775AA 1974-07-05 1975-07-03 Fremgangsmåde til fremstilling af mono-(hydroxyalkyl)-alkylxanthiner. DK140214B (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK169377A DK142790B (da) 1974-07-05 1977-04-15 Monoalken-1-yl-alkylxanthiner til anvendelse som mellemprodukter ved fremstilling af hydroxyalkyl-alkylxanthiner.
DK169277A DK169277A (da) 1974-07-05 1977-04-15 Fremgangsmade til fremstilling af mono(hydroxyalkyl)-alkylxathiner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (3)

Publication Number Publication Date
DK301775A DK301775A (en:Method) 1976-01-06
DK140214B DK140214B (da) 1979-07-09
DK140214C true DK140214C (en:Method) 1979-12-03

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK301775AA DK140214B (da) 1974-07-05 1975-07-03 Fremgangsmåde til fremstilling af mono-(hydroxyalkyl)-alkylxanthiner.

Country Status (14)

Country Link
JP (1) JPS5250800B2 (en:Method)
AR (1) AR210330A1 (en:Method)
AT (1) AT339917B (en:Method)
CA (1) CA1062710A (en:Method)
CH (2) CH622519A5 (en:Method)
DK (1) DK140214B (en:Method)
ES (1) ES439141A1 (en:Method)
FI (1) FI59249C (en:Method)
FR (1) FR2277089A1 (en:Method)
GB (1) GB1500039A (en:Method)
LU (1) LU72897A1 (en:Method)
NL (1) NL166476C (en:Method)
NO (1) NO143224C (en:Method)
SE (2) SE420097B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
LU72897A1 (en:Method) 1976-05-31
NL7507976A (nl) 1976-01-07
JPS5134194A (en:Method) 1976-03-23
SE7507726L (sv) 1976-01-07
NL166476C (nl) 1981-08-17
AU8275575A (en) 1977-01-06
NL166476B (nl) 1981-03-16
CH622519A5 (en) 1981-04-15
NO143224C (no) 1981-01-02
SE7807853L (sv) 1978-07-14
ES439141A1 (es) 1977-02-16
AT339917B (de) 1977-11-10
DK301775A (en:Method) 1976-01-06
SE427183B (sv) 1983-03-14
CH622018A5 (en) 1981-03-13
JPS5250800B2 (en:Method) 1977-12-27
NO143224B (no) 1980-09-22
FI751958A7 (en:Method) 1976-01-06
ATA517275A (de) 1977-03-15
GB1500039A (en) 1978-02-08
DK140214B (da) 1979-07-09
SE420097B (sv) 1981-09-14
NO752423L (en:Method) 1976-01-06
FI59249C (fi) 1981-07-10
CA1062710A (en) 1979-09-18
FR2277089A1 (fr) 1976-01-30
AR210330A1 (es) 1977-07-29
FI59249B (fi) 1981-03-31
FR2277089B1 (en:Method) 1978-03-17

Similar Documents

Publication Publication Date Title
FR2258498A1 (en:Method)
FI751543A7 (en:Method)
FR2277089B1 (en:Method)
DK149675A (en:Method)
CS164739B3 (en:Method)
CS168390B1 (en:Method)
CS175761B3 (en:Method)
CS169443B1 (en:Method)
CS173289B1 (en:Method)
DE2409712A1 (en:Method)
CH592788A5 (en:Method)
BG20520A1 (en:Method)
DD108635A1 (en:Method)
DD113723A1 (en:Method)
DD113881A1 (en:Method)
CH614948A5 (en:Method)
CH606389A5 (en:Method)
BG20518A1 (en:Method)
BG20475A1 (en:Method)
CH590164A5 (en:Method)
CH589329A5 (en:Method)
CH583133A5 (en:Method)
CH581368A5 (en:Method)
CH577249A5 (en:Method)
BG20648A1 (en:Method)

Legal Events

Date Code Title Description
PBP Patent lapsed